Ads
related to: news pfizer
Search results
Pfizer agrees to settle over 10,000 Zantac lawsuits, Bloomberg News reports
WSAU Wausau· 6 days ago(Reuters) -Pfizer has agreed to settle more than 10,000 lawsuits about cancer risks related to the...
Pfizer agrees to settle over 10K lawsuits linking Zantac to cancer
New York Post· 6 days agoThe lawsuits were filed in state courts across the country, but the agreements don’t completely...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 7 hours agoThis is part of an ongoing final-phase study in the Northern and Southern hemispheres. That's a drop...
Pfizer Follows Eli Lilly's Footsteps To Sell Medicines Directly To Patients
Benzinga via AOL· 1 day agoPfizer Inc (NYSE:PFE) is looking to build on the success of its COVID-19 vaccine rollout by...
Pfizer agrees to settle 10K Zantac lawsuits, as GSK trial links heartburn drug to cancer
BenefitsPRO· 5 days agoPfizer has agreed to settle more than 10,000 cases accusing it of hiding the cancer risks of its...
2 Beaten-Down Stocks to Buy and Hold for 10 Years
Motley Fool via Yahoo Finance· 4 days agoThat's why Pfizer's shares have failed to keep pace over the past two years. Here's the good news. Pfizer's coronavirus-related work ...
The Zacks Analyst Blog Highlights Amazon, Visa, Pfizer, Martin Marietta Materials and Zimmer Biomet
Zacks via Yahoo Finance· 1 day agoEvery day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and...
Pfizer to Settle 10K Lawsuits Over Drug Linked to Cancer, Costing Company Millions
IJR· 5 days agoBig Pharma giant Pfizer confirmed on Wednesday that it will settle more than 10,000 lawsuits over...
Pfizer whistleblower shares chilling video: ‘Tired of feeling like I have no hope…but I am NOT...
BizPac Review· 5 days agoA woman has come forward claiming to be a Pfizer whistleblower with a helluva story to tell about the pharmaceutical giant. In addition, she’s published an ominous video declaring ...
Moderna Stock Rebounds From Its RSV Vaccine Fallout — Is It A Buy, Again?
Investor's Business Daily· 6 hours agoThe news pushes back the potential approval date for Moderna's respiratory syncytial virus shot to...